Baystreet.ca - Psychedelics Could be Your Next Multi-Billion-Dollar Opportunity
Psychedelics Could be Your Next Multi-Billion-Dollar Opportunity It may only be a matter of time before mind-altering drugs make their way into Big Pharma treatments for mental health issues, such as depression, anxiety, obsessive compulsive disorder, trauma, and addiction. If that happens, the industry could be worth well over $100 billion, as noted by analyst at Eight Capital, benefiting companies such as Silo Wellness (CSE:SINO), Compass Pathways Inc. (NASDAQ:CMPS), HAVN Life Sciences Inc. (CSE:HAVN), and Tryp Therapeutics Inc. (CSE:TRYP). Helping even more, a bill to decrim...
Source: baystreet.ca